United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1993,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "b4dcccd1-c5ad-4f66-9d36-a9cb6857bdcc",
"title": "Stock Market Is Pricing A Never-Before-Seen 'Divergence' As Equities And Bonds 'Run It Hot' Amid Gloomy Outlook By Bottom-Up Analysts - Invesco QQQ Trust, Series 1 (NASDAQ:QQQ), SPDR S&P 500 (ARCA:SPY",
"description": "Stocks near all-time highs stand in contrast to the pessimistic views of the bottom-up analysts, according to Bob Elliott of Unlimited Funds.",
"keywords": "",
"snippet": "The financial markets are signaling a remarkably bullish outlook, with both stock and bond markets fully embracing a “run it hot” trade. However, this aggre...",
"url": "https://www.benzinga.com/general/market-summary/25/05/45641879/stock-market-is-pricing-a-never-before-seen-divergence-as-equities-and-bonds-run-it-hot-am",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/28/Wall-Street-Bull.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-28T12:28:40.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "QQQ",
"name": "Invesco QQQ Trust",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 116.34962,
"sentiment_score": 0.3093,
"highlights": [
{
"highlight": "The SPDR S&P 500 ETF Trust SPY and <em>I[+275 characters]",
"sentiment": 0.7717,
"highlighted_in": "main_text"
},
{
"highlight": "Stock Market Is Pricing A Never-Before-Seen 'Divergence' As Equities And Bonds 'Run It Hot' Amid Gloomy Outlook By Bottom-Up Analysts - <em>Invesco</em> <em>QQQ</em> <em>Trust</em>, Series 1 (<em>NASDAQ:QQQ</em>), SPDR S&P 500 (ARCA:SPY",
"sentiment": -0.1531,
"highlighted_in": "title"
}
]
},
{
"symbol": "SPY",
"name": "SPDR S&P 500 ETF Trust",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 53.83716,
"sentiment_score": 0.7717,
"highlights": [
{
"highlight": "The <em>SPDR</em> <em>S</em>&<em>P</em> [+302 characters]",
"sentiment": 0.7717,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "dd86d14d-8891-4a69-8644-8b15c19d2cc1",
"title": "DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Cytek Biosciences (NASDAQ:CTKB), Compass Diversified Hldgs (NYSE:CO",
"description": "",
"keywords": "",
"snippet": "U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Wednesday.\n\nShares of DHT Holdings, Inc. DHT fell sharply in pre-market ...",
"url": "https://www.benzinga.com/25/05/45641813/dht-holdings-posts-weak-sales-joins-compass-diversified-okta-and-other-big-stocks-moving-lower-in-wednesdays-pre-",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/28/Display-Of-Stock-Market-Quotes.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-28T12:24:06.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "GDS",
"name": "GDS Holdings Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 33.180748,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "<em>GDS</em> <em>Holdings</em> <em>Limit[+300 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "97c7985c-298a-4cb5-9d9b-7a40fcef0251",
"title": "These Analysts Slash Their Forecasts On Rocket Pharmaceuticals - Rocket Pharmaceuticals (NASDAQ:RCKT)",
"description": "",
"keywords": "",
"snippet": "Rocket Pharmaceuticals Inc RCKT announced an update Tuesday related to RP-A501, its investigational gene therapy for Danon disease, a rare X-linked dominant gen...",
"url": "https://www.benzinga.com/25/05/45641790/these-analysts-slash-their-forecasts-on-rocket-pharmaceuticals",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/28/Analyst-Woman-Working-With-Information-D.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-28T12:22:19.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCKT",
"name": "Rocket Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 133.0412,
"sentiment_score": 0.201667,
"highlights": [
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em>[+298 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em>[+311 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "These Analysts Slash Their Forecasts On <em>Rocket</em> <em>Pharmaceuticals</em> - <em>Rocket</em> <em>Pharmaceuticals</em> (<em>NASDAQ:RCKT</em>)",
"sentiment": -0.2732,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "a9281143-ddd7-4f83-a902-8338f6856046",
"title": "Kopin to be added to Russell 3000 and Russell 2000 indexes (NASDAQ:KOPN)",
"description": "Kopin (KOPN) will join the Russell 2000 Index after the 2025 reconstitution. Learn how this move may impact its growth and market visibility.",
"keywords": "",
"snippet": "Search field Entering text into the input field will update the search result below\n\nEntering text into the input field will update the search result below",
"url": "https://seekingalpha.com/news/4452899-kopin-to-be-added-to-russell-3000-and-russell-2000-indexes",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2025-05-28T12:05:17.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "KOPN",
"name": "Kopin Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 82.73866,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Kopin</em> to be added to Russell 3000 and Russell 2000 indexes (<em>NASDAQ:KOPN</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "43eeb09e-22ca-4c79-9477-178c965114bb",
"title": "Jim Cramer Says This Quantum Computing Stock Is 'So High' And 'Too Speculative' - GE Vernova (NYSE:GEV), IonQ (NYSE:IONQ)",
"description": "",
"keywords": "",
"snippet": "On CNBC's “Mad Money Lightning Round,” Jim Cramer said IonQ, Inc. IONQ is “so high,” and it's also losing so much money.” He added that it's “too sp...",
"url": "https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/28/Jim-Cramer.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-28T12:05:05.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "VRNA",
"name": "Verona Pharma plc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 43.215115,
"sentiment_score": 0.7217,
"highlights": [
{
"highlight": "<em>Verona</em> <em>Pharma</em> <em>plc<[+314 characters]",
"sentiment": 0.5455,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Verona</em> <em>Pharma</em> shares g[+205 characters]",
"sentiment": 0.8979,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LEU",
"name": "Centrus Energy Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 49.01483,
"sentiment_score": 0.7602,
"highlights": [
{
"highlight": "“What a horse,” Cramer said when ask[+335 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Centrus</em> <em>Energy</em> shares [+150 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b70287d2-3071-4f97-9b2c-f31c6161e4e5",
"title": "Pre-market Movers: SPRO, SGBX, BROG, LVWR, CETX…",
"description": "Massachusetts-based Spero Therapeutics, Inc. (SPRO), a clinical-stage biopharmaceutical company is up over 224 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.",
"keywords": "Pre-market Movers, pre-market",
"snippet": "The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.55 A.M. ET).\n\nIn the Green\n\nSpero Therapeutics, Inc. (SPRO) is...",
"url": "https://www.rttnews.com/3542479/pre-market-movers-spro-sgbx-brog-lvwr-cetx.aspx?type=ts",
"image_url": "https://cdn.rttnews.com/articleimages/ustopstories/2025/may/buysellstock-17012025_28may25-lt.jpg",
"language": "en",
"published_at": "2025-05-28T12:04:09.000000Z",
"source": "rttnews.com",
"relevance_score": null,
"entities": [
{
"symbol": "BROG",
"name": "Brooge Energy Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 45.815056,
"sentiment_score": 0.4404,
"highlights": [
{
"highlight": "<em>Brooge</em> <em>Energy</em> <em>Limi[+334 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CETX",
"name": "Cemtrex, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 35.644695,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "In the Red\n\n<em>Cemtrex</em>, <em>Inc</e[+326 characters]",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CETXP",
"name": "Cemtrex, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 35.644695,
"sentiment_score": -0.2263,
"highlights": [
{
"highlight": "In the Red\n\n<em>Cemtrex</em>, <em>Inc</e[+326 characters]",
"sentiment": -0.2263,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NLSP",
"name": "NLS Pharmaceutics AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 63.186966,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>NLS</em> <em>Pharmaceutics</em> <em>[+310 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "BROGW",
"name": "Brooge Energy Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 45.791416,
"sentiment_score": 0.4404,
"highlights": [
{
"highlight": "<em>Brooge</em> <em>Energy</em> <em>Limi[+334 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NLSPW",
"name": "NLS Pharmaceutics AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 63.181877,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>NLS</em> <em>Pharmaceutics</em> <em>[+310 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "89cc805a-9e27-4b07-9109-6506bd771ee6",
"title": "This Informatica Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday - Informatica (NYSE:INFA), Rocket Pharmaceuticals (NASDAQ:RCKT)",
"description": "",
"keywords": "",
"snippet": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...",
"url": "https://www.benzinga.com/25/05/45641392/this-informatica-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-wednesday",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/28/Side-View-Of-Concentrated-Crypto-Trader-.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-28T12:04:07.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCKT",
"name": "Rocket Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 93.80387,
"sentiment_score": 0.158533,
"highlights": [
{
"highlight": "Jefferies analyst Andrew Tsai downgraded[+321 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em>[+312 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "This Informatica Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday - Informatica (NYSE:INFA), <em>Rocket</em> <em>Pharmaceuticals</em> (<em>NASDAQ:RCKT</em>)",
"sentiment": -0.1027,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5bdaae99-6e57-4726-b2ad-989ff7c29d3a",
"title": "How Will Guess Stock React To Its Upcoming Earnings?",
"description": "Traditionally, GES stock has seen an increase 63% of the time following earnings reports, with a median one-day gain of 10.3% and an observed maximum increase of 26%.",
"keywords": "guess stock, guess, ges revenue, ges earnings",
"snippet": "NEW YORK, NEW YORK - APRIL 09: A Guess store is seen on April 09, 2025 in New York City. U.S. ... More President Donald Trump has announced that he will pause t...",
"url": "https://www.forbes.com/sites/greatspeculations/2025/05/28/how-will-guess-stock-react-to-its-upcoming-earnings/",
"image_url": "https://imageio.forbes.com/specials-images/imageserve/683685850a2c1e0879def97d/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
"language": "en",
"published_at": "2025-05-28T12:00:00.000000Z",
"source": "forbes.com",
"relevance_score": null,
"entities": [
{
"symbol": "GES",
"name": "Guess', Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 48.923355,
"sentiment_score": 0.302733,
"highlights": [
{
"highlight": "NEW YORK, NEW YORK - APRIL 09: A <em>Gue[+240 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Santiago/Getty Images) Getty Images\n\n<em[+332 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Guess</em> is reevaluating its strat[+303 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, refer to Buy or Sell <em>G[+180 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Here is some historical performance data[+299 characters]",
"sentiment": 0.3939,
"highlighted_in": "main_text"
},
{
"highlight": "How Will <em>Guess</em> Stock React To Its Upcoming Earnings?",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "001f6143-87e6-4d27-8740-bff45b6b42ff",
"title": "5 Things to Know Before the Stock Market Opens",
"description": "U.S. stock futures are little changed Wednesday, with Nvidia set to report its highly anticipated first-quarter results after the bell. Here's what investors need to know today.",
"keywords": "",
"snippet": "U.S. stock futures are little changed following yesterday's rally as investors watch for key earnings today; Nvidia (NVDA) and Salesforce (CRM) are expected to ...",
"url": "https://www.investopedia.com/5-things-to-know-before-the-stock-market-opens-may-28-2025-11742968",
"image_url": "https://www.investopedia.com/thmb/dIPzGPRDHNaKgq777a6nXEKCr9A=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2216930902-d6fbafc6ba4d48b6a21ad2b1cdb3362a.jpg",
"language": "en",
"published_at": "2025-05-28T11:40:43.000000Z",
"source": "investopedia.com",
"relevance_score": null,
"entities": [
{
"symbol": "PCYG",
"name": "Park City Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 12.074493,
"sentiment_score": -0.2023,
"highlights": [
{
"highlight": "The leadership change comes as Vail shar[+144 characters]",
"sentiment": -0.2023,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "b0ab6a5e-1c5a-47b2-a826-99cc68a5d832",
"title": "What’s Next For OKTA Stock?",
"description": "The company’s performance exceeded the Wall Street expectations in both earnings and revenue but it was the guidance that didn’t sit well with the investors.",
"keywords": "okta, okta revenue, okta margins, okta earnings, okta valuation, stock, nasdaq, s&p500",
"snippet": "CANADA - 2025/01/31: In this photo illustration, the Okta, Inc. logo is seen displayed on a ... More smartphone screen. (Photo Illustration by Thomas Fuller/SOP...",
"url": "https://www.forbes.com/sites/greatspeculations/2025/05/28/whats-next-for-okta-stock/",
"image_url": "https://imageio.forbes.com/specials-images/imageserve/67c861472f16e7b957b83336/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
"language": "en",
"published_at": "2025-05-28T10:38:28.000000Z",
"source": "forbes.com",
"relevance_score": null,
"entities": [
{
"symbol": "OKTA",
"name": "Okta, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 70.77233,
"sentiment_score": 0.3823,
"highlights": [
{
"highlight": "CANADA - 2025/01/31: In this photo illus[+97 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(Photo Illustration by Thomas Fuller/SOP[+336 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "For the quarter, <em>Okta</em> reported [+263 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "OKTA’s Q1 Performance Driven By Impres[+254 characters]",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "Beyond top-line growth, <em>Okta</em> al[+315 characters]",
"sentiment": 0.9169,
"highlighted_in": "main_text"
},
{
"highlight": "For fiscal 2026, <em>Okta</em> anticipat[+244 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "What’s Next For <em>OKTA</em> Stock?",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "OKTA.MX",
"name": "Okta, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 54.927956,
"sentiment_score": 0.3823,
"highlights": [
{
"highlight": "CANADA - 2025/01/31: In this photo illus[+97 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(Photo Illustration by Thomas Fuller/SOP[+327 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "For the quarter, <em>Okta</em> reported [+263 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "OKTA’s Q1 Performance Driven By Impres[+254 characters]",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "Beyond top-line growth, <em>Okta</em> al[+315 characters]",
"sentiment": 0.9169,
"highlighted_in": "main_text"
},
{
"highlight": "For fiscal 2026, <em>Okta</em> anticipat[+244 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "What’s Next For <em>OKTA</em> Stock?",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0KB7.L",
"name": "Okta, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 54.919125,
"sentiment_score": 0.3823,
"highlights": [
{
"highlight": "CANADA - 2025/01/31: In this photo illus[+97 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(Photo Illustration by Thomas Fuller/SOP[+327 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "For the quarter, <em>Okta</em> reported [+263 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "OKTA’s Q1 Performance Driven By Impres[+254 characters]",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "Beyond top-line growth, <em>Okta</em> al[+315 characters]",
"sentiment": 0.9169,
"highlighted_in": "main_text"
},
{
"highlight": "For fiscal 2026, <em>Okta</em> anticipat[+244 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "What’s Next For <em>OKTA</em> Stock?",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "O1KT34.SA",
"name": "Okta, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 54.910538,
"sentiment_score": 0.3823,
"highlights": [
{
"highlight": "CANADA - 2025/01/31: In this photo illus[+97 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(Photo Illustration by Thomas Fuller/SOP[+327 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "For the quarter, <em>Okta</em> reported [+263 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "OKTA’s Q1 Performance Driven By Impres[+254 characters]",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "Beyond top-line growth, <em>Okta</em> al[+315 characters]",
"sentiment": 0.9169,
"highlighted_in": "main_text"
},
{
"highlight": "For fiscal 2026, <em>Okta</em> anticipat[+244 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "What’s Next For <em>OKTA</em> Stock?",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "19a66008-0c9e-4966-b333-cf416dfb4737",
"title": "Spero stock rises on data for GSK-partnered UTI drug (GSK:NYSE)",
"description": "Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 trial. Read more here.",
"keywords": "",
"snippet": "Nano-cap U.S. biotech Spero Therapeutics (NASDAQ:SPRO) added ~255% in the premarket on Wednesday after the company and its partner GSK (NYSE:GSK) announced that...",
"url": "https://seekingalpha.com/news/4452881-spero-stock-rises-data-gsk-partnered-uti-drug",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1499014978/image_1499014978.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-05-28T11:52:28.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SPRO",
"name": "Spero Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.964146,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Nano-cap U.S. biotech <em>Spero</em> <em[+244 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "6ebb785a-8d91-41f9-bfaa-b917703ee84a",
"title": "Prime Announces Selection of Ausenco to Lead PEA Study Work",
"description": "**media[639048]**",
"keywords": "Prime, Announces, Selection, of, Ausenco, to, Lead, PEA, Study, Work",
"snippet": "Preliminary Economic Assessment Targeted for Completion in Q3/2025\n\n[with Clarification of Current Drilling Status]\n\nVANCOUVER, British Columbia, May 28, 2025 (...",
"url": "https://www.manilatimes.net/2025/05/28/tmt-newswire/globenewswire/prime-announces-selection-of-ausenco-to-lead-pea-study-work/2122377",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/28/639048.jpg",
"language": "en",
"published_at": "2025-05-28T11:39:09.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "PRMNF",
"name": "Prime Mining Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 20.729393,
"sentiment_score": 0.31625,
"highlights": [
{
"highlight": "Preliminary Economic Assessment Targeted[+184 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(\"Prime” or the \"Company”) (TSX: PRY[+310 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Prime</em> <em>Mining</em>\n\nPr[+290 characters]",
"sentiment": 0.9468,
"highlighted_in": "main_text"
},
{
"highlight": "For further information, please visit ht[+311 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3091,
"sentiment_avg": 0.27586384371517875
}
]
}
Other details
Entity count
- 32,649